In these included studies, 22 studies observed the correlation between COX-2 expression and risk of laryngeal cancer, and 46 reports involved the associations of COX-2 expression with clinical characteristics of laryngeal cancer. Here, PTGS2 is linked to laryngeal carcinoma.